Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.7 USD | +3.49% |
|
+13.07% | -25.32% |
07-15 | Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating | MT |
07-01 | NeuroPace, Inc.(NasdaqGM:NPCE) added to Russell Small Cap Completeness Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.32% | 214M | |
+2.62% | 209B | |
+6.44% | 183B | |
+29.61% | 158B | |
+34.96% | 114B | |
+3.84% | 67.29B | |
+17.38% | 54.83B | |
-4.51% | 46.88B | |
-5.77% | 38.58B | |
+3.71% | 36.65B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating